Skip to content

Salmeterol xinafoate

Serevent (salmeterol xinafoate) is a small molecule pharmaceutical. Salmeterol xinafoate was first approved as Serevent on 1994-02-04. It is used to treat asthma and bronchial spasm in the USA. It is known to target beta-2 adrenergic receptor.
Trade Name Serevent
Common Name Salmeterol xinafoate
Indication asthma, bronchial spasm
Drug Class Bronchodilators (phenethylamine derivatives); anti-inflammatory agents (salicylic acid derivatives)
Salmeterol xinafoate
Get full access now